美股市场个股详情
DGX 奎斯特诊疗
- 162.660
- -0.660-0.40%
收盘价 11/29 13:00 (美东)
- 162.660
- 0.0000.00%
盘后 17:02 (美东)
181.55亿总市值21.86市盈率TTM
163.770最高价161.670最低价42.75万股成交量162.240今开163.320昨收6963.83万成交额0.39%换手率21.72市盈率(静)1.12亿总股本165.32052周最高2.67市净率180.03亿流通值121.08452周最低2.96股息TTM1.11亿流通股165.320历史最高1.82%股息率TTM1.29%振幅2.583历史最低162.902平均价1股每手
关于奎斯特诊疗公司
奎斯特诊疗公司从事诊断测试、信息和服务的提供。它通过诊断信息服务(DIS)和所有其他部门运作。DIS分部为患者、临床医生、医院、健康计划和雇主提供诊断信息服务。所有其他部门包括风险评估服务、医疗信息技术、诊断产品和临床试验测试业务。
公司介绍
公司代码DGX
公司名称奎斯特诊疗
上市日期1996/12/17
成立日期1967
CEOMr. James E. Davis
所属市场纽交所
员工数量48000
年结日12-31
公司地址500 Plaza Drive
城市Secaucus
省份新泽西
国家美国
邮编07940
电话1-973-520-2700
董事高管
- 姓名
- 职务
- 年薪
- James E. Davis
- Chairman of the Board, President and Chief Executive Officer
- 1267.38万
- Sam A. Samad
- Executive Vice President and Chief Financial Officer
- 397.51万
- Michael J. Deppe
- Senior Vice President, Corporate Controller and Chief Accounting Officer
- --
- Mark Delaney
- Senior Vice President and Chief Commercial Officer
- --
- Patrick Plewman
- Senior Vice President, Diagnostic Services
- --
- Michael E. Prevoznik
- Senior Vice President and General Counsel
- 225.19万
- Karthik Kuppusamy
- Senior Vice President, Clinical Solutions
- 201.52万
- Catherine T. Doherty
- Senior Vice President, Regional Businesses
- 315.88万
- Mark A. Gardner
- Senior Vice President, Molecular Genomics and Oncology
- --
- Timothy L. Main
- Independent Director
- 31.54万
- Robert B. Carter
- Independent Director
- --
- Tracey C. Doi
- Independent Director
- 30.04万
- Denise M. Morrison
- Independent Director
- 31.23万
- Dr. Luis A. Diaz, Jr,M.D.
- Independent Director
- 28.04万
- Timothy M. Ring
- Lead Independent Director
- 34.59万
- Gary M. Pfeiffer
- Independent Director
- 34.21万
- Vicky B. Gregg
- Independent Director
- 31.57万
- Wright L. Lassiter, III
- Independent Director
- 30.04万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据
